DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?

Arch Dermatol. 2012 Mar;148(3):381-4. doi: 10.1001/archdermatol.2011.3014.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Chromosome Aberrations*
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 2 / genetics*
  • Genes, Recessive / genetics*
  • Hereditary Autoinflammatory Diseases / drug therapy*
  • Hereditary Autoinflammatory Diseases / genetics*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / genetics
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Psoriasis / drug therapy*
  • Psoriasis / genetics*

Substances

  • Antirheumatic Agents
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein

Supplementary concepts

  • Deficiency of interleukin-1 receptor antagonist